Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Patrinia villosa water extract (PVW) is an aqueous extract derived from the medicinal herb *Patrinia villosa* (Thunb.) Dufr., which has a history of use in traditional Chinese medicine for treating intestinal disorders. The extract contains various bioactive compounds, including 8,9-didehydro-7-hydroxydolichodial (DHD), a heat-generated compound formed during thermal hydrolysis. Research in preclinical models of colorectal cancer has demonstrated that PVW exhibits anti-tumor effects by inhibiting cell viability and migration, primarily through the upregulation of tumor suppressor proteins p53 and PTEN. Additionally, the extract has shown pro-angiogenic activity via the activation of focal adhesion kinase (FAK). Studies also suggest that PVW can enhance the efficacy of the FOLFOX chemotherapy regimen (5-fluorouracil, folinic acid, and oxaliplatin) in colon cancer models without interfering with the metabolism of the chemotherapy components.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on patrinia villosa water extract.